News About: Goverment
The approval for the insurance benefit of ‘Nexavar’… the birth of the only treatment of thyroid cancer‘Nexavar’, a well-known drug for liver cancer, will be permitted to be prescribed for thyroid cancer patients.
After the review of the Cancer Deliberation Committee last month,...
|
.jpg)
The Ministry of Health and Welfare stated “The ‘adoption first, adjust later’ promise will be kept”
The Ministry of Health and Welfare decided to improve the 7 issues exposed from the process of the Diagnosis Related Group Payment System (DRG).
Young-rae Son, director of the Health Service Department, the Ministry ...
The prohibition of mixed display of pharmaceutical and non-pharmaceutical products will soon be abolished
It is expected that the Ministry of Food and Drug Safety will abolish the prohibition on mixed display of pharmaceutical and non-pharmaceutical products within this year. It was the sequential abolishment after the Mi...
The marginal structure with high pharmaceutical distribution margin, worth of KRW 2.6 trillion
Congressman Yong-ik Kim from the New Politics Alliance for Democracy pointed out the need for revised pharmaceutical distribution structure as the margin rate of domestic pharmaceutical wholesalers has exceeded KRW 2....
What is the possibility for the maximum volume of acetaminophen to be changed?
The request of acetaminophen volume reduction, which has been brought up several years, has continued this year again.
To reduce the maximum dose per a time and the maximum volume per a day is the gist.
In order to ...
Ministry of Food and Drug Safety turned in the final draft of Patent Linkage System to the National Assembly
The final draft of Patent Linkage System that sets basis of drug sales restriction has been confirmed, and submitted to the National Assembly.
In order to enforce the Patent Linkage System followed by the Korea-US FT...
Possibility of economical saving through generic substitution with less expecsive products for more than KRW 300 billion
It was suggested that over KRW 300 billion of the health insurance budget can be saved if generic substitution for same component drugs is activated.
Congressman Dong-ik Choi in the Health and Welfare Committee of th...
Innovation pharmaceutical companies has received huge benefits through corporate tax reductionSince innovation pharmaceutical companies were chosen, the government has supported the companies more than what people has expected for the last 3 years.
It was not as enough ...
|
‘Two different results’ of Xtandi vs Zytiga
New drugs for late state prostate cancer had two different results.
While Astellas Pharmaceutical’s ‘Xtandi Capsule(Enzalutamide)’ is registered on the positive list, Janssen’s ‘Zytiga Tab(Abiraterone Acetate)’ could...
The National Assembly was focused on examination in regards to social contribution and clinical trials of multinational pharmaceutical companies
Health and Welfare Committee of the National Assembly conducted witness examination at the national inspection on this 20th to check if multinational pharmaceutical companies have contributed enough to the Korean soci...
